1. Home
  2. RZLT vs IHRT Comparison

RZLT vs IHRT Comparison

Compare RZLT & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • IHRT
  • Stock Information
  • Founded
  • RZLT 2010
  • IHRT 1974
  • Country
  • RZLT United States
  • IHRT United States
  • Employees
  • RZLT N/A
  • IHRT N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • RZLT Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • RZLT Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • RZLT 819.3M
  • IHRT 454.9M
  • IPO Year
  • RZLT N/A
  • IHRT 2019
  • Fundamental
  • Price
  • RZLT $9.49
  • IHRT $3.20
  • Analyst Decision
  • RZLT Strong Buy
  • IHRT Buy
  • Analyst Count
  • RZLT 6
  • IHRT 3
  • Target Price
  • RZLT $14.50
  • IHRT $2.92
  • AVG Volume (30 Days)
  • RZLT 1.5M
  • IHRT 587.1K
  • Earning Date
  • RZLT 11-07-2025
  • IHRT 11-10-2025
  • Dividend Yield
  • RZLT N/A
  • IHRT N/A
  • EPS Growth
  • RZLT N/A
  • IHRT N/A
  • EPS
  • RZLT N/A
  • IHRT N/A
  • Revenue
  • RZLT N/A
  • IHRT $3,867,156,000.00
  • Revenue This Year
  • RZLT N/A
  • IHRT $0.22
  • Revenue Next Year
  • RZLT N/A
  • IHRT $6.06
  • P/E Ratio
  • RZLT N/A
  • IHRT N/A
  • Revenue Growth
  • RZLT N/A
  • IHRT 3.18
  • 52 Week Low
  • RZLT $2.22
  • IHRT $0.95
  • 52 Week High
  • RZLT $10.04
  • IHRT $3.51
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 59.75
  • IHRT 59.29
  • Support Level
  • RZLT $9.00
  • IHRT $2.61
  • Resistance Level
  • RZLT $9.89
  • IHRT $3.51
  • Average True Range (ATR)
  • RZLT 0.58
  • IHRT 0.20
  • MACD
  • RZLT 0.01
  • IHRT 0.03
  • Stochastic Oscillator
  • RZLT 81.06
  • IHRT 69.31

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: